{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:37:16Z","timestamp":1790386636509,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1996,10,1]],"date-time":"1996-10-01T00:00:00Z","timestamp":844128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1996,10]]},"DOI":"10.1016\/0145-2126(95)00156-5","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T19:51:38Z","timestamp":1027626698000},"page":"867-876","source":"Crossref","is-referenced-by-count":31,"title":["Combined differentiating therapy for myelodysplastic syndromes: A phase II study"],"prefix":"10.1016","volume":"20","author":[{"given":"Dario","family":"Ferrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Pregno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Larizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Ciravegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Luraschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Vietti-Ramus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piercarla","family":"Schinco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Bazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenic","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/0145-2126(95)00156-5_BIB1","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1200\/JCO.1990.8.8.1424","article-title":"The myelodysplastic syndromes: biology and implications for management","volume":"8","author":"List","year":"1990","journal-title":"J. clin. Oncol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0889-8588(18)30328-9","article-title":"Molecular genetic aspects of myelodysplastic syndromes","volume":"6","author":"Bartram","year":"1992","journal-title":"Hematology\/Oncology Clinics North Am."},{"key":"10.1016\/0145-2126(95)00156-5_BIB3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/blood.V73.1.248.248","article-title":"Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin","volume":"73","author":"Janssen","year":"1989","journal-title":"Blood"},{"key":"10.1016\/0145-2126(95)00156-5_BIB4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V79.1.198.198","article-title":"Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies","volume":"79","author":"Mangi","year":"1992","journal-title":"Blood"},{"key":"10.1016\/0145-2126(95)00156-5_BIB5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2141.1985.tb07361.x","article-title":"The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations","volume":"59","author":"Tricot","year":"1985","journal-title":"Br. J. Haematol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.1985.tb07329.x","article-title":"Myelodysplastic syndromes: a scoring system with prognostic significance","volume":"59","author":"Mufti","year":"1985","journal-title":"Br. J. Haematol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB7","first-page":"141","article-title":"Myelodysplastic syndromes: a multiparametric study of prognostic factors and a proposed scoring system","volume":"75","author":"Cassano","year":"1990","journal-title":"Haematologica"},{"key":"10.1016\/0145-2126(95)00156-5_BIB8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0889-8588(18)30330-7","article-title":"A guide to risk assessment in the primary myelodysplastic syndrome","volume":"6","author":"Mufti","year":"1992","journal-title":"Hematology\/Oncology Clinics North Am."},{"key":"10.1016\/0145-2126(95)00156-5_BIB9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0609.1990.tb00425.x","article-title":"Risk assessment in myelodysplastic syndromes: value of clinical hematologic and bone marrow histologic findings at presentation","volume":"45","author":"Morra","year":"1990","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB10","first-page":"444","article-title":"Management of myelodysplastic syndromes","volume":"14","author":"Tricot","year":"1987"},{"key":"10.1016\/0145-2126(95)00156-5_BIB11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-8588(18)30332-0","article-title":"Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes","volume":"6","author":"Loffler","year":"1992","journal-title":"Hematology\/Oncology Clinics North Am."},{"key":"10.1016\/0145-2126(95)00156-5_BIB12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V82.2.677.677","article-title":"Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome","volume":"82","author":"Anderson","year":"1993","journal-title":"Blood"},{"key":"10.1016\/0145-2126(95)00156-5_BIB13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0950-3536(05)80284-7","article-title":"Low dose chemotherapy and differentiating agents","volume":"4","author":"Chomienne","year":"1991","journal-title":"Balli\u00e8re's clin. Haematol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood.V71.3.703.703","article-title":"Randomized study of 13-cis-retinoic acid versus placebo in myelodysplastic disorders","volume":"71","author":"Koeffler","year":"1988","journal-title":"Blood"},{"key":"10.1016\/0145-2126(95)00156-5_BIB15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1200\/JCO.1986.4.4.589","article-title":"13-cis retinoic acid treatment for myelodysplastic syndromes","volume":"4","author":"Picozzi","year":"1986","journal-title":"J. din. Oncol"},{"key":"10.1016\/0145-2126(95)00156-5_BIB16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1182\/blood.V67.5.1323.1323","article-title":"Disappearance of cytogenetic abnormalities and clinical remission during therapy with 13-cis-retinoic acid in a patient with myelodysplastic syndrome: inhibition of growth of the patient's malignant monocytoid clone","volume":"67","author":"Abrahm","year":"1986","journal-title":"Blood"},{"key":"10.1016\/0145-2126(95)00156-5_BIB17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(87)92796-6","article-title":"Effect of 13-cis RA on the survival of patients with myelodysplastic syndromes","volume":"i","author":"Clark","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/0145-2126(95)00156-5_BIB18","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood.V81.5.1152.1152","article-title":"Treatment of myelodysplastic syndromes with all-trans retinoic acid","volume":"81","author":"Ohno","year":"1993","journal-title":"Blood"},{"key":"10.1016\/0145-2126(95)00156-5_BIB19","first-page":"1399","article-title":"1-25-OH-Vitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells","volume":"69","author":"Koeffler","year":"1985","journal-title":"Cancer Treatment Rep."},{"key":"10.1016\/0145-2126(95)00156-5_BIB20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajh.2830230212","article-title":"A treatment of myelodysplastic syndrome with 1,25 dihydroxy-vitamin D3","volume":"23","author":"Richard","year":"1986","journal-title":"Am. J. Hematol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB21","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1182\/blood.V80.10.2604.2604","article-title":"Hexamethylene bis-acetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent","volume":"80","author":"Andreff","year":"1992","journal-title":"Blood"},{"key":"10.1016\/0145-2126(95)00156-5_BIB22","first-page":"480","article-title":"Recombinant gammainterferon as first line therapy for high risk myelodysplastic syndromes","volume":"4","author":"Maiolo","year":"1990","journal-title":"Leukemia"},{"key":"10.1016\/0145-2126(95)00156-5_BIB23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mpo.2950160105","article-title":"Treatment of myelodysplastic syndromes with low dose 6-thioguanine","volume":"16","author":"Spitzer","year":"1988","journal-title":"Med. Ped. Oncol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB24","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood.V64.4.922.922","article-title":"5-Aza-2\u2032-deoxycytidine induces terminal differentiation of leukemic blasts from patients with AML","volume":"64","author":"Pinto","year":"1984","journal-title":"Blood"},{"key":"10.1016\/0145-2126(95)00156-5_BIB25","first-page":"153","article-title":"Low dose ARA-C for patients with myelodysplastic syndromes","volume":"2","author":"Powell","year":"1988","journal-title":"Leukemia"},{"key":"10.1016\/0145-2126(95)00156-5_BIB26","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1200\/JCO.1986.4.12.1857","article-title":"A critical appraisal of low dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes","volume":"4","author":"Cheson","year":"1986","journal-title":"J. clin. Oncol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0145-2126(85)90136-5","article-title":"Synergistic interaction between differentiation inducers and DNA inhibitors: a new approach to differentiation induction in myelodysplasia and acute leukemia","volume":"9","author":"Francis","year":"1985","journal-title":"Leukemia Res."},{"key":"10.1016\/0145-2126(95)00156-5_BIB28","first-page":"100","article-title":"Self-renewal inhibition of acute myeloid leukemia clonogenic cells by biological inducers of differentiation","volume":"6","author":"Ferrero","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/0145-2126(95)00156-5_BIB29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0145-2126(90)90039-C","article-title":"Triple combination of retinoic acid +6-thioguanine + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture","volume":"14","author":"Tawhid","year":"1990","journal-title":"Leukemia Res."},{"key":"10.1016\/0145-2126(95)00156-5_BIB30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0145-2126(87)90033-6","article-title":"Effects of Interferon and retinoic acid on the growth and differentiation of clonogenic leukemic cell from acute myelogenous leukemia patients treated with recombinant leukocyte-alpha interferon","volume":"11","author":"Gallagher","year":"1987","journal-title":"Leukemia Res."},{"key":"10.1016\/0145-2126(95)00156-5_BIB31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0145-2126(87)90115-9","article-title":"Differentiation induction in myelodysplasia and acute myeloid leukemia: use of synergistic drug combinations","volume":"11","author":"Francis","year":"1987","journal-title":"Leukemia Res."},{"key":"10.1016\/0145-2126(95)00156-5_BIB32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br. J. Haematol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB33","first-page":"909","article-title":"Classification of the myelodysplastic syndromes","volume":"15","author":"Bennett","year":"1986","journal-title":"Clinics Haematol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0145-2126(80)90068-5","article-title":"Mechanisms of glucocorticoid activity in patients with the preleukemic syndrome (hematopoietic dysplasia)","volume":"4","author":"Bagby","year":"1980","journal-title":"Leukemia Res."},{"key":"10.1016\/0145-2126(95)00156-5_BIB35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.1987.tb06893.x","article-title":"A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome","volume":"66","author":"Clark","year":"1987","journal-title":"Br. J. Haematol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-0609.1990.tb00470.x","article-title":"Treatment of myelodysplastic syndromes with retinoic acid and 1-hydroxyvitamin D3 in combination with low-dose ARA-C is not superior to ARA-C alone. Results from a randomized study","volume":"45","author":"Hellstrom","year":"1990","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/0145-2126(95)00156-5_BIB37","series-title":"Retinoids in Oncology","first-page":"127","article-title":"Clinical toxicity of retinoics","author":"Dimery","year":"1993"},{"key":"10.1016\/0145-2126(95)00156-5_BIB38","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V78.7.1658.1658","article-title":"Pharmacological doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes","volume":"78","author":"Stein","year":"1991","journal-title":"Blood"},{"key":"10.1016\/0145-2126(95)00156-5_BIB39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0889-8588(18)30333-2","article-title":"Treatment of myelodysplastic syndromes with hematopoietic growth factors","volume":"6","author":"Ganser","year":"1992","journal-title":"Hematology\/Oncology Clinics North Am."},{"key":"10.1016\/0145-2126(95)00156-5_BIB40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0145-2126(91)90009-I","article-title":"Induction of granulocytic maturation in acute myeloid leukemia by G-CSF and retinoic acid","volume":"15","author":"Santini","year":"1991","journal-title":"Leukemia Res."},{"key":"10.1016\/0145-2126(95)00156-5_BIB41","first-page":"951","article-title":"Interactions between retinoic acid and colony stimulating factors affecting the blasts cells of acute myeloblastic leukemia","volume":"5","author":"Tohda","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/0145-2126(95)00156-5_BIB42","first-page":"30","article-title":"5-aza-2\u2032deoxycytidine (Decitabine) induce trilineage response in unfavourable myelodysplastic syndromes","volume":"7","author":"Zagonel","year":"1993","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212695001565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212695001565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T15:48:41Z","timestamp":1580312921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0145212695001565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1996,10]]}},"alternative-id":["0145212695001565"],"URL":"https:\/\/doi.org\/10.1016\/0145-2126(95)00156-5","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[1996,10]]}}}